LPCN 8-K 2026-10-07

Lipocine Inc. (LPCN) 8-K dated 2026-10-07 — accession 0001493152-26-046060. This URL is the filing, not the LPCN hub.

Lipocine Inc. (LPCN) is a biotechnology company listed on NASDAQ.

Lipocine Inc. filed a 8-K on 2026-10-07. Accession 0001493152-26-046060.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported LPCN revenue for 2025-12-31 was $2.0M. Net income was -$9.6M. Revenue was up 169.3% from 2023-12-31 to 2025-12-31. LPCN currently screens at market cap $19.3M.

Not investment advice. The LPCN SEC hub lists recent forms. The stock page is the research view.